Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome

Explore clinical trials studying Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome trial results

Completed

Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)

NCT02878798

Conditions: Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Barrow Neurological Institute Phoenix, Arizona, United States

University of California Irvine Orange, California, United States

University of Miami Miami, Florida, United States

View all 20 locations

View Trial Details